PATENT CLAIM ANALYSIS

Application Number: 15918582
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "464000"]

Abstract:
The present invention relates to a solid pharmaceutical dosage forms and methods for preparing the solid pharmaceutical dosage form that contains fingolimod or its pharmaceutically acceptable salts, conjugates or complexes thereof. The solid pharmaceutical dosage forms may rapidly disintegrates in a patient's oral cavity.

Claim (Index 34):
A method for treating multiple sclerosis comprising the step of administering to a patient in need of such treatment, the solid oral dosage form of  claim 28 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.2973
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15084226', '13564362', '14087903', '13183119', '13719640']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.714167936354673
- 35 USC 102 Novelty (BERT): 0.5421060024194797
- Combined Prediction Score: 0.6969617429611538
- Mean Citation Score: 241.714678
- Max Citation Score: 402.46573
- Similarity Product: 270.15859388507783

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test